News: Express Scripts Holding Co (ESRX.O)

ESRX.O on Nasdaq

82.34USD
26 Nov 2014
Price Change (% chg)

$0.82 (+1.01%)
Prev Close
$81.52
Open
$81.65
Day's High
$82.38
Day's Low
$81.35
Volume
2,978,945
Avg. Vol
3,684,729
52-wk High
$82.38
52-wk Low
$64.64

Search Stocks
Select another date:

Fri, Nov 14 2014

Berkshire invests in Express Scripts, makes confidential disclosure

- Warren Buffett's Berkshire Hathaway Inc disclosed a new stake in healthcare management company Express Scripts Holding Co and shed its stake in agricultural equipment maker Deere & Co, among several changes in its stock investments during the third quarter.

Berkshire invests in Express Scripts, makes confidential disclosure

Nov 14 - Warren Buffett's Berkshire Hathaway Inc disclosed a new stake in healthcare management company Express Scripts Holding Co and shed its stake in agricultural equipment maker Deere & Co, among several changes in its stock investments during the third quarter.

Express Scripts says AbbVie drug could displace Sovaldi on formulary

- Pharmacy benefit manager Express Scripts Holding Co said it may quickly change its preferred drug formulary to favor an expected new hepatitis C drug from AbbVie if it is clinically equivalent and less costly than Gilead Science Inc's $84,000 Sovaldi and $94,500 Harvoni treatments.

Express Scripts says AbbVie drug could displace Sovaldi on formulary

Oct 29 - Pharmacy benefit manager Express Scripts Holding Co said it may quickly change its preferred drug formulary to favor an expected new hepatitis C drug from AbbVie if it is clinically equivalent and less costly than Gilead Science Inc's $84,000 Sovaldi and $94,500 Harvoni treatments.

BRIEF-Express Scripts says may change formulary in mid-2015 due to "unsustainable" cost of Gilead's Sovaldi

Oct 29 - Express Scripts Holding Co : * Says may change drug formulary in mid-2015 to favor expected new hepatitis c

Walgreen to sell drugs under Express Scripts 2015 Medicare plans

- Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said Walgreen Co would sell prescription drugs under its two Medicare Part D plans for 2015.

UPDATE 2-Walgreen to sell drugs under Express Scripts 2015 Medicare plans

Oct 1 - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said Walgreen Co would sell prescription drugs under its two Medicare Part D plans for 2015.

Express Scripts 2015 Medicare drug plans to be available at Walgreen

Oct 1 - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said its two Medicare Part D prescription drug plans would be available at Walgreen Co as part of Express Scripts' preferred pharmacy network.

Novo Nordisk aims for 2016 Tresiba launch in U.S

COPENHAGEN - Novo Nordisk <NOVOb.CO said on Thursday it could launch its new long-acting insulin Tresiba, a crucial future growth driver for the Danish company, at the start of 2016 in the United States.

UPDATE 2-Novo Nordisk aims for 2016 Tresiba launch in U.S.

* Shares up 1.5 pct (Adds comments from CEO, analysts, share price)

Select another date:
Search Stocks